FDAnews
www.fdanews.com/articles/191860-biotronik-earns-ce-mark-for-injectable-cardiac-monitor

BioTronik Earns CE Mark for Injectable Cardiac Monitor

July 2, 2019

BioTronik’s injectable cardiac monitor for tracking arrhythmias, the BioMonitor III, has earned the CE Mark and is now available on the European market.

The device is designed to help patients with irregular heart rhythms by detecting and recording suspected arrhythmia and unexplained loss of consciousness caused by low blood pressure.

The monitor works in conjunction with the devicemaker’s home monitoring system and requires no patient interaction.

View today's stories